Manager, FP&A

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China's National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: Reporting to the Associate Director, FP&A, this position partners closely with functional leaders and FP&A/Accounting teams to deliver monthly financial reporting, compare actual results against forecast and budget, support budgeting and strategic/financial planning, and drive improvements in reporting processes and data transparency. It is a high-impact role for a detail-oriented analyst who will provide the insights needed for executive decision-making. Role and Responsibilities: Assist in the preparation of the annual operating plan, quarterly forecasts, and long-range models for CMC, Supply Chain, and Medical Affairs Provide planning, reporting, and analysis of COGS, identifying drivers, risks, and opportunities Perform detailed financial analysis, provide insights, and prepare monthly reporting packages for functional teams to track spending against budget Partner with supply chain, procurement, and operations to evaluate cost drivers and identify savings opportunities Manage and review the purchasing plan forecast to align with the clinical supply chain during monthly S&OP Review and evaluate contracts for financial implications, cost structures, and risk exposure Partner with the Accounting team during month-end close to review accruals and track activities across various projects and cost centers Proactively identify opportunities to streamline financial processes and enhance standard product cost analysis Assist with ad hoc projects as needed All other duties as assigned Experience, Education and Specialized Knowledge and Skills: Minimum bachelor's degree in Finance, Accounting and Business Administration Minimum 5+ years of experience in budgeting and financial Results-oriented, strong organizational skills, and time management skills with ability to multi-task Strong analytical, problem-solving and financial modeling skills Advanced Excel skills Demonstrated ability to operate in a fast-paced environment Attention to detail, accuracy and confidentiality An ability to work well cross…

View the full posting and apply